Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 4/20 | 0.34 |
| ▸ | CNR1 | P21554 | 2/20 | 0.33 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.33 |
| ▸ | CETP | P11597 | 1/20 | 0.33 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2868769 | 0.78 | NOTUM (0.45) | NOTUMCNR1ALDH1A1CHRNA7 | |
| SCHEMBL1660370 | 0.75 | KDM4E (0.34) | SLC6A1KDM4EALDH1A1 | |
| SCHEMBL2323764 | 0.75 | KDM4E (0.52) | NOTUMKDM4EALDH1A1 | |
| SCHEMBL2318440 | 0.74 | CYP1A1 (0.42) | NOTUM | |
| SCHEMBL15562144 | 0.69 | NOTUM (0.53) | NOTUMHTR2CCNR1PTPN5 | |
| SCHEMBL21777036 | 0.65 | NOTUM (0.61) | NOTUMHTR2CCNR1CETPPTPN5 | |
| SCHEMBL7325347 | 0.64 | AR (0.35) | KDM4EALDH1A1 | |
| SCHEMBL6009742 | 0.64 | MEN1 (0.45) | KDM4E | |
| SCHEMBL25406026 | 0.63 | NOTUM (0.49) | NOTUMHTR2CCNR1PTPN5DGAT1 | |
| SCHEMBL21776968 | 0.63 | NOTUM (1.00) | NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2307394-A2 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Amorepacific Corporation (KR) | 2011-04-13 | — | — | EP | disclosed |
| WO-2010002209-A2 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | AMOREPACIFIC CORPORATION (KR) | 2010-01-07 | — | — | WO | disclosed |